Introduction {#S0001}
============

Antimicrobial resistance (AMR) is of global concern as the widespread detection of carbapenemase-producing Enterobacteriaceae (CPE) is an emerging issue with potentially serious public health implications.[@CIT0001] New Delhi metallo-β-lactamase (NDM) confers resistance to β-lactams with the exception of aztreonam, and the rapid global spread of NDM-1-producing strains has raised serious concerns that common infections with these organisms may soon be untreatable.[@CIT0002] Variants of NDM carbapenemase have been assigned to *bla*~NDM-27~ under curation by the National Database of Antibiotic Resistant Organisms (NDARO, <https://www.ncbi.nlm.nih.gov/pathogens/isolates#/refgene/blaNDM>). NDM-5 was first reported in 2011 in the United Kingdom and was isolated from a multidrug-resistant *Escherichia coli* ST648 clinical isolate from a patient with a recent history of hospitalization in India.[@CIT0003]

NDM-5 exhibits expanded-spectrum cephalosporins and carbapenems degradation with two amino acid substitutions (Val88Leu and Met154Leu) in the NDM-1 amino acid sequence[@CIT0003] NDM-5 has been characterized as exhibiting higher hydrolytic activity than other variants (NDM-1, NDM-4, NDM-6, and NDM-7).[@CIT0004]

NDM-5-producing Enterobacteriaceae have been identified from many different sources in multiple countries. Thus far, it has been reported that *bla*~NDM-5~ appears to be predominant among all potential carbapenemase genes (including other NDM variants and KPC-2) in China.[@CIT0005] Moreover, diverse dissemination of the *bla*~NDM-5~ gene has been detected among non-clonal *E. coli* hosts (ST12, ST167, ST354, ST361, ST410, ST617, ST746, ST6335, and ST6395) via the IncX3 plasmid in China.[@CIT0006],[@CIT0007] To elucidate the dissemination of CPE including NDM variants, AMR monitoring of wastewater treatment plant (WWTP) effluent contributes to the detection of ongoing AMR bacterial dissemination in environment, and might provide early warning of potential dissemination in clinical settings and communities.

Here, we isolated an NDM-5-producing *E. coli* strain GSH8M-2 from an effluent sampled at a WWTP in Tokyo Bay, Japan. Then, we determined the complete genome sequence of GSH8M-2, and characterized the genetic features of *bla*~NDM-5~- and *bla*~CTX-M-55~-positive plasmids.

Materials and methods {#S0002}
=====================

Bacterial strains and identification {#S0002-S2001}
------------------------------------

The upper effluent flow from an urban WWTP was collected on August 6, 2018, in the canal (N35.631783, E139.7448151) at Tokyo Bay, Japan. The facilities of the WWTP process an influent by biological reactors and disinfection with chlorination. Average water qualities of pH, biochemical oxygen demand, and chemical oxygen demand are pH 6.8, 16, and 12 mg/L, respectively. The treated effluent sample in this study was collected within five consecutive days without recent rainfall to exclude the effect of the weather. Then, bacteria within the effluent sample were isolated as described previously for CPE.[@CIT0008] Briefly, 500 mL of effluent was filtered, and the membrane incubated in 20 mL of LB-broth supplemented with 1 mg/L meropenem at 37°C for 14 hrs, after which the culture was spread onto CHROMagar extended-spectrum β-lactamase (ESBL) plates (CHROMagar, Paris, France).

Antimicrobial susceptibility and CPE screening tests {#S0002-S2002}
----------------------------------------------------

Antimicrobial susceptibility was investigated by E test (bioMérieux, Marcy-l'Étoile, France) according to the European Committee on Antimicrobial Susceptibility Testing guideline v9.0. Carbapenemase production was assessed by performing a Carba NP test, as described previously.[@CIT0009]

Whole-genome sequence analysis {#S0002-S2003}
------------------------------

Determination of the complete genome sequence was performed as described, previously.[@CIT0010] Briefly, the complete genome sequence was determined using an Illumina NextSeq 500 (2×150-mer, 350× median coverage) (Illumina, San Diego, CA, USA), followed by a PacBio Sequel sequencer for long-read sequencing (PacBio, Menlo Park, CA, USA). A de novo assembly was performed.[@CIT0010] Annotation was conducted in DFAST.[@CIT0011] Multilocus Sequence Typing was characterized at the pubMLST site (<https://pubmlst.org/escherichia/>). Circular representations of complete genome sequences were visualized using the GView server.[@CIT0012] AMR genes were identified by homology searching against the ResFinder database.[@CIT0013] Plasmid replicon typing was performed using the curated PlasmidFinder database at the CGE website (<https://cge.cbs.dtu.dk//services/PlasmidFinder/>).[@CIT0014]

Comparative plasmid genome network analysis {#S0002-S2004}
-------------------------------------------

Complete plasmid sequences were retrieved from NCBI "nt" and "RefSeq" database using a keyword search for the words "complete sequence" and "plasmid", followed by gene prediction using the Prodigal program for normalization of gene finding. A plasmid network analysis was performed as previously described.[@CIT0015] In brief, amino acid sequences for the complete plasmids were clustered using the UCLUST program (version 6.0.307)[@CIT0016] with the following parameters: cluster_smallmem; id 1.0 (100% identity in amino acid sequence); target_cov 0.9, query_cov 0.9 (at least 90% coverage); minsl 0.9, minqt 0.9, maxqt 1.1 (less than 10% difference in length). Each plasmid, ranging from 30 to 60 kb in size, was connected to a network under the sharing threshold with at least 40 homologous genes, followed by community assignment using the multilevel community method in the R igraph library. In order to visualize the level of similarity for individual plasmid sequences in a dataset, non-metric multidimensional scaling analysis was performed with the distance matrix calculated with the Simpson's index using the metaMDS program from Vegan R package. The Cytoscape version 3.2.0 was used to draw the plasmid network graph.[@CIT0017]

Results {#S0003}
=======

NDM-5-producing E. coli strain GSH8M-2 {#S0003-S2001}
--------------------------------------

The isolated *E. coli* effluent strain GSH8M-2 was Carba NP test positive. MIC testing suggested that GSH8M-2 was highly resistant to the β-lactams, fluoroquinolone, trimethoprim-sulfamethoxazole, and chloramphenicol, kanamycin, and fosfomycin. However, it was still susceptible to colistin and aminoglycosides (amikacin, gentamicin, streptomycin, and tobramycin) except kanamycin ([Table 1](#T0001){ref-type="table"}).Table 1Antimicrobial susceptibility test in *E. coli* GSH8M-2Antimicrobial agentsMinimum inhibitory concentration (mg/L)SIR (EUCAST ver 9.0)Ampicillin-sulbactam\>256RCefepime32RCefotaxime\>32RCeftazidime\>256RImipenem\>32RMeropenem\>8RAztreonam16RAmikacin2SGentamicin1STobramycin1SKanamycin\>256--Streptomycin8--Tetracycline\>256--Ciprofloxacin0.5ILevofloxacin4RAzithromycin8--Trimethoprim-sulfamethoxazole\>32RChloramphenicol\>256RColistin0.125SFosfomycin\>1024R[^1]

Genome features of E. coli strain GSH8M-2 {#S0003-S2002}
-----------------------------------------

The complete genome sequence was determined, as described in the materials and methods. GSH8M-2 carries multiple antimicrobial resistance genes (ARGs) for β-lactams (*bla*~NDM-5~, *bla*~CTX-M-55~, *bla*~EC~, and *bla*~TEM-135~), quinolone (*qnrS1* and *qnrS2*), tetracycline (t*et* (A)), trimethoprim-sulfamethoxazole (*dfrA14* and *dfrA17*), florfenicol/chloramphenicol (*floR*), kanamycin (*aph (3ʹ)-Ia*), and fosfomycin (*fosA3*).

Importantly, IncX3 plasmid pGSH8M-2--4 (46.1 kb) carries *bla*~NDM-5~ ([Figure 1A](#F0001){ref-type="fig"}), exhibiting an almost identical gene organization to pNDM-MGR194, which was first identified in IncX3 plasmids carrying *bla*~NDM-5~ in *Klebsiella pneumoniae* MGR-194 clinical isolates in India[@CIT0018] ([Figure 1B](#F0001){ref-type="fig"}). These two *bla*~NDM-5~-positive IncX3 plasmids showed partially distinct gene organization around the *bla*~NDM-1~ to IncX3 plasmid in p112298-NDM, which was first identified in 2013 in a *Citrobacter freundii* strain 112298 in China.[@CIT0019]Figure 1Plasmid analysis of pGSH8M-2--4 and pGSH8M-2--3. (**A**) Circular representation of pGSH8M-2-4. ORFs were painted with color by predicted gene function; *bla*~NDM-5~, red; replication, brown; insertion sequences, light blue; conjugal transfer related genes, orange. (**B**) Structural comparison of the IncX3 plasmids carrying *bla*~NDM~-positive plasmids. A pairwise nucleotide % identity is shown as red (forward orientation) and blue (complementary orientation) between plasmid sequences. pNDM-MGR194 (GenBank ID: KF220657) was first identified IncX3 plasmids carrying *bla*~NDM-5~ in *Klebsiella pneumoniae* in India. p112298-NDM (GenBnak ID: KP987216), IncX3 plasmid carrying *bla*~NDM-1~ instead of *bla*~NDM-5~, was identified in *Citrobacter freundii* strain 112298 in China in 2013. (**C**) Circular representation of pGSH8M-2-3. (**D**) Structural comparison of the IncX1 plasmids similar to pGSH8M-2-3. *bla*~CTX-M-55~ was found in pGSH8M-2-3, not but in pD72-IncX1 (GenBank ID: CP035315) in *E. coli* D72 isolated from pig in China, and plasmid C (GenBank ID: CP010155) in *E. coli* D9 isolated from dog.

IncX1 plasmid pGSH8M-2--3 (49.3 kb) carries multiple ARGs including *bla*~CTX-M-55~, *aph(3ʹ)-Ia, floR, fosA3*, and *qnrS2* ([Figure 1C](#F0001){ref-type="fig"}). Blast homology search revealed that three publicly complete sequences (two plasmids and one chromosome DNA of *E. coli* strains isolated from a dog and pig) showed homology with \>80% region coverage, for all three plasmids sharing the *aph(3ʹ)-Ia, floR*, and *qnrS2* for three primarily veterinary use antimicrobials (aminoglycosides, florfenicol, and quinolone, respectively) ([Figure 1D](#F0001){ref-type="fig"}). However, pGSH8M-2--3 carries additional *bla*~CTX-M-55~ and *fosA3* with IS*26* mediated acquisition ([Figure 1D](#F0001){ref-type="fig"}).

Plasmid gene network analysis of IncX3 plasmids {#S0003-S2003}
-----------------------------------------------

To further elucidate the dissemination of *bla*~NDM-5~-positive IncX3 plasmids, gene clustering, and network analysis was performed using the IncX3 plasmids relevant to pGSH8M-2--4, resulting in 141 plasmid entries obtained from a public database ([[Table S1](https://www.researchgate.net/publication/334129079_Supplemental_Table-S1)]{.ul}). Those 142 plasmid sequences were classified into four communities ([Figure 2](#F0002){ref-type="fig"}). The pGSH8M-2--4 strain originated from a community (C1) that shares *bla*~NDM-5~ with *E. coli* and *Klebsiella* clinical isolates in Eastern Asia. Of note, the community network analysis strongly suggested that *bla*~NDM-5~-positive IncX3 plasmids are of clonal lineage, but horizontally disseminated over multiple bacteria hosts (*Escherichia, Klebsiella, Enterobacter, Citrobacter*, and *Kluyvera*). On the other hand, other β-lactamases \[*bla*~NDM-1~, *bla*~KPC~, *bla*~OXA-181~, and ESBL gene-positive IncX3 plasmids can be clustered into different communities from each other (C2, C3, and C4 in [Figure 2](#F0002){ref-type="fig"}), because of horizontal acquisition with extra adjacent genes around the ARGs ([Figure 1B](#F0001){ref-type="fig"}). Thus, each β-lactamase-positive IncX3 plasmid appears to have disseminated in an independent manner among Enterobacteriaceae.Figure 2Plasmid gene network analysis using pGSH8M-2-4 related sequences. Using pGSH8M-2-4 sequence as query, 141 IncX3 plasmid sequences were obtained from the public database. In total, 142 plasmid sequences (see [[Table S1](https://www.researchgate.net/publication/334129079_Supplemental_Table-S1)]{.ul}), each plasmid can be clustered into four communities (C1--C4). A circle indicates the clustering position of each plasmid, highlighted with the indicated color based on the type of β-lactamase, genus, place, and source of isolation.

Discussion {#S0004}
==========

In this study, we isolated the NDM-5-producing *E. coli* strain (GSH8M-2) from effluent of a WWTP in Tokyo Bay, Japan. This is the first report of an environmental NDM-5-producing *E. coli* isolate from a WWTP in Japan. Thus far, the detection of NDM variants in clinical settings is very rare and uncommon in Japan, a few reports suggested that NDM-5-producing *E. coli* and *K. pneumoniae* were identified in a Japanese individual traveling to Bangladesh in 2013 and also in a case in Indonesia in 2014. However, both of these were imported cases to Japan not a local occurrence.[@CIT0020] Thus, our findings in this study may indicate an emerging public health issue within the Japanese community.

In addition, previous environmental studies have suggested that NDM-5-producing Enterobacteriaceae have been detected in an urban river in Montpellier, France,[@CIT0021] hospital sewage water in India[@CIT0022] and Taiwan,[@CIT0023] and effluent from a WWTP in Switzerland.[@CIT0024] Although a few studies revealed dissemination of environmental NDM variants, WWTPs could be a primary source of most AMR bacteria in aquatic environments, because of the partial purification that occurs during the wastewater treatment processes. In particular, ongoing global dissemination could be archived by the rapid spread of the IncX3 replicon-based plasmid transmission among Enterobacteriaceae ([Figure 2](#F0002){ref-type="fig"}).

In addition to NDM-5, GSH8M-2 harbors CTX-M-55, which was first reported in 2006 in Thailand[@CIT0025] and is a variant of CTX-M-15 in the CTX-M-1 cluster, with only one amino acid substitution (Ala~80~Val). Over the past decade, CTX-M-55-producing *E. coli* isolated from animals and in clinical settings has been increasing.[@CIT0026] Moreover, the *bla*~CTX-M-55~-positive plasmid pGSH8M-2-3 is associated with other ARGs (*aph(3ʹ)-Ia, floR, fosA3*, and *qnrS2*), the co-localization of the florfenicol resistance gene *floR* is of marked concern because *floR is* detected in increasing amounts in both veterinary[@CIT0027] and clinical isolates[@CIT0028] within China. Therefore, CTX-M-55-positive *E. coli* could disseminate in other settings under highly selective pressure by co-selection of the veterinary antimicrobials (florfenicol) and clinical use (cephalosporin) and has become one of the most important emergent AMR bacteria in environment. These findings suggest that the dissemination of dual β-lactamase (carbapenemase and ESBL)-positive bacteria has become a global issue, and environmental contamination could act as a reservoir of NDM variants-producing AMR Enterobacteriaceae.

Conclusions {#S0005}
===========

AMR monitoring of WWTP effluent may contribute to the detection of emerging AMR bacterial dissemination in clinical settings and communities. A comprehensive approach based on the complete determination of the genome sequence including the AMR plasmid will be required in order to fully understand AMR dissemination of these bacterial clones and relevant AMR plasmids within the environment.
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Data availability {#S0006}
=================

The complete, annotated genome sequence of *E. coli* GSH8M-2 was deposited in a public database as shown in [Table 2](#T0002){ref-type="table"}. The short- and long-read sequences for DNA-Seq were deposited in the DNA Data Bank of Japan (BioProject PRJDB6962; BioSample SAMD00168435; DRA accession DRA008278).Table 2Whole genome information of *E. coli* GSH8M-2 from WWTP effluentRepliconGC%Length (bp)MLSTInc typeDrug Resistance GeneGenBank IDChromosome50.94,693,292ST542--*aadA5, bla*~EC~, *dfrA17*AP019675pGSH8M-2--151.0145,389--IncFIB(AP001918), IncFII, IncFII(pSE11)*bla*~TEM-135~, *dfrA14, floR, qnrS1, tet*(A) ×2AP019676pGSH8M-2--252.475,556--IncFII(pCoo)*floR*AP019677pGSH8M-2--346.349,365--IncX1*aph(3ʹ)-Ia, bla*~CTX-M-55~, *floR, fosA3, qnrS2*AP019678pGSH8M-2--446.746,158--IncX3*bla*~NDM-5~AP019679pGSH8M-2--543.23,274--Col440I--AP019680pGSH8M-2--646.93,067--Col440I--AP019681[^2][^3]

Author contributions {#S0007}
====================

TS and MK contributed to the isolation of the NDM-5 producing strains. TS, YI, and MK performed the genome sequencing and the comparative genome analysis. TS and MK performed antimicrobial susceptibility testing. MK wrote the manuscript. All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure {#S0008}
==========

The authors report no conflicts of interest in this work.

[^1]: **Note:** --, not defined in EUCAST.

[^2]: **Note:** --, not availabale
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